The RAS-related GTPase RHOB confers resistance to EGFR-tyrosine kinase inhibitors in non-small-cell lung cancer via an AKT-dependent mechanism.
Calvayrac O, Mazières J, Figarol S, Marty-Detraves C, Raymond-Letron I, Bousquet E, Farella M, Clermont-Taranchon E, Milia J, Rouquette I, Guibert N, Lusque A, Cadranel J, Mathiot N, Savina A, Pradines A, Favre G.
Calvayrac O, et al. Among authors: bousquet e.
EMBO Mol Med. 2017 Feb;9(2):238-250. doi: 10.15252/emmm.201606646.
EMBO Mol Med. 2017.
PMID: 28003335
Free PMC article.